KR100486961B1 - 성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 - Google Patents
성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 Download PDFInfo
- Publication number
- KR100486961B1 KR100486961B1 KR10-2002-0057662A KR20020057662A KR100486961B1 KR 100486961 B1 KR100486961 B1 KR 100486961B1 KR 20020057662 A KR20020057662 A KR 20020057662A KR 100486961 B1 KR100486961 B1 KR 100486961B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- ginseng
- parts
- deep
- purified
- Prior art date
Links
- 230000001568 sexual effect Effects 0.000 title abstract description 7
- 235000013305 food Nutrition 0.000 title description 5
- 238000002360 preparation method Methods 0.000 title description 2
- 239000013535 sea water Substances 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 241000411851 herbal medicine Species 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000012676 herbal extract Substances 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 8
- 244000020518 Carthamus tinctorius Species 0.000 claims description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- IQULGZQMMPRBLA-UHFFFAOYSA-N 2-carboxyethylgermanium Chemical compound OC(=O)CC[Ge] IQULGZQMMPRBLA-UHFFFAOYSA-N 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 7
- 241000792859 Enema Species 0.000 claims description 6
- 239000007920 enema Substances 0.000 claims description 6
- 229940079360 enema for constipation Drugs 0.000 claims description 6
- 235000013311 vegetables Nutrition 0.000 claims description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 240000001810 Angelica gigas Species 0.000 claims description 2
- 235000018865 Angelica gigas Nutrition 0.000 claims description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims 4
- 229960003604 testosterone Drugs 0.000 claims 2
- 241000125175 Angelica Species 0.000 claims 1
- 244000184734 Pyrus japonica Species 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 abstract description 59
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 57
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 57
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 abstract description 45
- 229910052732 germanium Inorganic materials 0.000 abstract description 33
- 235000015872 dietary supplement Nutrition 0.000 abstract description 19
- 230000036299 sexual function Effects 0.000 abstract description 15
- 230000002708 enhancing effect Effects 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 8
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 6
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 6
- 229940010454 licorice Drugs 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 6
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract description 5
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract description 5
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract description 5
- 210000003056 antler Anatomy 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000002075 main ingredient Substances 0.000 abstract description 2
- 241000208340 Araliaceae Species 0.000 abstract 17
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 42
- 239000003814 drug Substances 0.000 description 24
- 230000000694 effects Effects 0.000 description 24
- 201000001880 Sexual dysfunction Diseases 0.000 description 17
- 231100000872 sexual dysfunction Toxicity 0.000 description 17
- 210000005226 corpus cavernosum Anatomy 0.000 description 16
- 229910052760 oxygen Inorganic materials 0.000 description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- 239000001301 oxygen Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000001881 impotence Diseases 0.000 description 9
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 8
- 230000004064 dysfunction Effects 0.000 description 8
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000010228 Erectile Dysfunction Diseases 0.000 description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 description 7
- 210000000702 aorta abdominal Anatomy 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 210000003899 penis Anatomy 0.000 description 7
- 239000000902 placebo Substances 0.000 description 7
- 229940068196 placebo Drugs 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000009986 erectile function Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 208000019622 heart disease Diseases 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 230000007012 clinical effect Effects 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229960001789 papaverine Drugs 0.000 description 4
- 230000018052 penile erection Effects 0.000 description 4
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 4
- 229960001999 phentolamine Drugs 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 3
- 229960000711 alprostadil Drugs 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000001800 adrenalinergic effect Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 229960003310 sildenafil Drugs 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 description 2
- 229960003991 trazodone Drugs 0.000 description 2
- 210000000626 ureter Anatomy 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 229960000317 yohimbine Drugs 0.000 description 2
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 241000276420 Lophius piscatorius Species 0.000 description 1
- 206010024870 Loss of libido Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010057672 Male sexual dysfunction Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 239000003048 aphrodisiac agent Substances 0.000 description 1
- 230000002509 aphrodisiac effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000011646 bottled functional water Nutrition 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940015688 caverject Drugs 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000008738 huangbai Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229940028444 muse Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001107 psychogenic effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
- 해저 600m의 심층수와 1400m의 심층수를 정제하여 1: 1 비율로 혼합한 정제된 심층수 68중량%; 시호 9 중량부, 홍화 9 중량부, 도인 9 중량부, 적작약 9 중량부, 천궁 9 중량부, 당귀 9 중량부, 숙지 30 중량부, 자석영 20 중량부, 길경 5 중량부 및 우슬 5 중량부를 열수 1140 중량부에 투입하여 열수 추출한 10%짜리 한약재 추출물 30중량%; 및 카르복시 에틸 게르마늄 32 산화물 2중량%로 구성되는 것을 특징으로 하는 성기능 강화에 효과적인 건강보조식품.
- 해저 600m의 심층수와 1400m의 심층수를 취하여 -4 ∼ 0℃의 온도를 유지하면서 1일간 정치하여 침전물을 제거한 후에 여과하는 방법으로 정제한 다음, 해저 600m의 심층수와 1400m의 심층수를 1 : 1의 비율로 혼합하는 단계; 시호 9 중량부, 홍화 9 중량부, 도인 9 중량부, 적작약 9 중량부, 천궁 9 중량부, 당귀 9 중량부, 숙지 30 중량부, 자석영 20 중량부, 길경 5 중량부 및 우슬 5 중량부를 열수 1140 중량부에 투입하여 6시간 동안 열수 추출한 다음, 실온으로 냉각하고 1일간 정치한 후, 침전물을 제거하여 10% 짜리 한약재 추출물을 준비하는 단계; 상기 심층수(선도액) 혼합물 68중량%, 상기 한약재 추출물 30중량% 및 식물성 카르복시 에틸 게르마늄 32 산화물 2중량%를 혼합하고 교반하여 식물성 카르복시 에틸 게르마늄 32 산화물이 완전히 용해되고, 각각의 성분들이 균질하게 혼합되도록 하여 제조하는 것을 특징으로 하는 성기능 강화에 효과적인 건강보조식품의 제조방법.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0057662A KR100486961B1 (ko) | 2002-09-23 | 2002-09-23 | 성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0057662A KR100486961B1 (ko) | 2002-09-23 | 2002-09-23 | 성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040026277A KR20040026277A (ko) | 2004-03-31 |
KR100486961B1 true KR100486961B1 (ko) | 2005-05-03 |
Family
ID=37328773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0057662A KR100486961B1 (ko) | 2002-09-23 | 2002-09-23 | 성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100486961B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104825728A (zh) * | 2015-04-28 | 2015-08-12 | 成都中医药大学 | 一种治疗口腔扁平苔藓的药物制剂 |
CN104826007A (zh) * | 2015-04-28 | 2015-08-12 | 成都中医药大学 | 一种具有增强糜烂型口腔扁平苔藓局部愈合的漱口制剂及其制备方法 |
KR102180363B1 (ko) | 2019-05-14 | 2020-11-19 | 주식회사 대화바이오 | 검은 참깨와 효모 가수분해물을 함유하는 남성 성기능 개선용 조성물 |
KR20230089796A (ko) | 2021-12-14 | 2023-06-21 | 이경태 | 천연물을 포함하는 남성에너지 드링크 및 그 제조방법 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100692173B1 (ko) * | 2005-03-23 | 2007-03-12 | 손병국 | 신장활성과 항피로, 강정, 강장, 성기능 개선용 건강식품 |
KR100692175B1 (ko) * | 2005-03-25 | 2007-03-12 | 손병국 | 신장활성과 항피로, 강정, 강장, 성기능 개선용 건강기능식품 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960016779A (ko) * | 1994-11-14 | 1996-06-17 | 강성훈 | 보건혼합음료 조성물 |
KR970068894A (ko) * | 1996-04-24 | 1997-11-17 | 강대일 · 정영숙 | 미네랄, 생약재엑기스 및 아미노산이 함유된 건강식품조성물 |
JP2002119263A (ja) * | 2000-10-16 | 2002-04-23 | Kazuhiro Kotani | 海洋深層水を利用したスポーツドリンク |
KR20020085003A (ko) * | 2001-05-03 | 2002-11-16 | 이태호 | 게르마늄으로 숙성 시킨 자라 엑기스 제조 방법. |
KR20020090444A (ko) * | 2001-05-25 | 2002-12-05 | 한국식품개발연구원 | 남성 성기능 개선용 기능성 식품 |
-
2002
- 2002-09-23 KR KR10-2002-0057662A patent/KR100486961B1/ko active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960016779A (ko) * | 1994-11-14 | 1996-06-17 | 강성훈 | 보건혼합음료 조성물 |
KR970068894A (ko) * | 1996-04-24 | 1997-11-17 | 강대일 · 정영숙 | 미네랄, 생약재엑기스 및 아미노산이 함유된 건강식품조성물 |
JP2002119263A (ja) * | 2000-10-16 | 2002-04-23 | Kazuhiro Kotani | 海洋深層水を利用したスポーツドリンク |
KR20020085003A (ko) * | 2001-05-03 | 2002-11-16 | 이태호 | 게르마늄으로 숙성 시킨 자라 엑기스 제조 방법. |
KR20020090444A (ko) * | 2001-05-25 | 2002-12-05 | 한국식품개발연구원 | 남성 성기능 개선용 기능성 식품 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104825728A (zh) * | 2015-04-28 | 2015-08-12 | 成都中医药大学 | 一种治疗口腔扁平苔藓的药物制剂 |
CN104826007A (zh) * | 2015-04-28 | 2015-08-12 | 成都中医药大学 | 一种具有增强糜烂型口腔扁平苔藓局部愈合的漱口制剂及其制备方法 |
KR102180363B1 (ko) | 2019-05-14 | 2020-11-19 | 주식회사 대화바이오 | 검은 참깨와 효모 가수분해물을 함유하는 남성 성기능 개선용 조성물 |
KR20230089796A (ko) | 2021-12-14 | 2023-06-21 | 이경태 | 천연물을 포함하는 남성에너지 드링크 및 그 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20040026277A (ko) | 2004-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2276460T3 (es) | Extractos de plantas que tienen actividad supresora del apetito. | |
Kenner et al. | Botanical medicine: a European professional perspective | |
EP2255818A1 (en) | Oral or enteral composition useful for recovery of physical functions | |
JP2011504884A (ja) | うつおよび不安の治療のための医薬組成物 | |
JPH10114649A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
Nation et al. | Clinical signs and studies of the site of action of purified larkspur alkaloid, methyllycaconitine, administered parenterally to calves | |
KR100486961B1 (ko) | 성기능 강화에 효과적인 건강보조식품 및 이의 제조방법 | |
US20180177714A1 (en) | A highly concentrated seawater mineral extract and uses thereof | |
CN102309004A (zh) | 一种降胆固醇的功能性保健食品 | |
CN110772564A (zh) | 一种具有调节抑郁情绪作用的中药提取物组合物及其制备方法和中药制剂 | |
KR100475196B1 (ko) | 탈모방지 또는 발모에 효과적인 건강보조식품 및 이의 제조방법 | |
CN110123858A (zh) | 一种云木香精油的应用 | |
CN110123989A (zh) | 一种莪术精油的应用 | |
DE60124516T2 (de) | Kombination des lezithins mit ascorbinsäure | |
KR100486963B1 (ko) | 당뇨병 치료 및 예방에 효과적인 건강보조식품 및 이의제조방법 | |
JP5403320B2 (ja) | 天然抽出物より得られた脱顆粒抑制剤、β−ヘキソサミニダーゼ遊離抑制剤、抗アレルギー剤および抗炎症剤 | |
KR100486960B1 (ko) | 고혈압에 효과적인 건강보조식품 및 이의 제조방법 | |
CN107362245A (zh) | 一种具有抗氧化和降同型半胱氨酸的组合物 | |
JP2003502376A (ja) | 性機能障害および血管収縮に関する疾患の予防および治療におけるイカリンの使用 | |
CN110123982A (zh) | 一种草果精油的应用 | |
KR100526639B1 (ko) | 위암에 대한 항암 및 제암 효과를 갖는 건강보조식품 및 이의 제조방법 | |
KR20000002474A (ko) | 퇴행성 대뇌 신경계 질환의 예방 및 치료제 | |
KR100475197B1 (ko) | 스트레스 해소에 효과적인 건강보조식품 및 이의 제조방법 | |
KR20040026273A (ko) | 치매에 효과적인 건강보조식품 및 이의 제조방법 | |
KR19980043964A (ko) | 종합기침약 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130416 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140425 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150423 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160425 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170425 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180625 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190423 Year of fee payment: 15 |